Initial Workup and Management for Delirium
The initial workup for delirium should focus on identifying and treating the underlying causes through a comprehensive assessment of predisposing and precipitating factors, while implementing non-pharmacological interventions as first-line management before considering pharmacological options. 1
Diagnosis and Assessment
Clinical Evaluation
- Diagnose delirium using DSM or ICD criteria by a trained healthcare professional 2
- Look for cardinal features:
- Acute onset (hours to days) and fluctuating course
- Disturbed level of consciousness
- Change in cognition (disorientation, memory impairment)
- Perceptual disturbances 1
- Identify delirium subtype: hyperactive, hypoactive, or mixed 1
- Hypoactive delirium is often underdiagnosed but is the most prevalent subtype in palliative care 2
Initial Workup
Laboratory investigations:
- Complete blood count
- Comprehensive metabolic panel (electrolytes, BUN, creatinine)
- Calcium, magnesium levels
- Glucose
- Thyroid function tests
- Urinalysis
- Blood cultures if infection suspected 2
Imaging and additional tests (as indicated):
Medication review:
Management Approach
Non-Pharmacological Interventions (First-Line)
Environmental modifications:
- Ensure adequate lighting during day, reduce at night
- Minimize noise and patient transfers
- Place familiar objects, calendars, and clocks for orientation 1
Cognitive support:
- Frequent reorientation
- Cognitive stimulation through appropriate activities
- Clear communication 1
Sensory optimization:
- Ensure eyeglasses and hearing aids are available
- Check for impacted ear wax 1
Early mobilization:
- Avoid unnecessary bed rest and physical restraints
- Assist with ambulation at least three times daily when possible 1
Sleep-wake cycle regulation:
- Increase daylight exposure during waking hours
- Reduce noise and light during nighttime
- Avoid daytime napping 1
Pharmacological Management (Second-Line)
For moderate delirium symptoms:
For severe delirium with agitation:
For refractory agitation:
For opioid-induced delirium:
Special Considerations
Reversibility
- 20-50% of delirium episodes can be reversed in patients with advanced cancer who are not imminently dying 2
- Medication-induced delirium is usually reversible, while delirium due to hypoxic encephalopathy or organ failure is often irreversible 2
Refractory Delirium in End-of-Life Care
- If delirium is due to disease progression in dying patients:
Patient and Family Support
- Provide education about delirium to family members
- Explain the fluctuating nature of symptoms
- Support caregivers in coping with this distressing condition 2, 1
Common Pitfalls to Avoid
- Failing to recognize hypoactive delirium (more common but less obvious than hyperactive delirium)
- Missing fluctuating symptoms with single assessments (perform multiple evaluations)
- Using benzodiazepines as first-line treatment (can worsen delirium)
- Overlooking non-pharmacological interventions before medication
- Inadequate collection of collateral history to establish baseline cognitive function 1
Remember that delirium is associated with increased mortality, longer hospital stays, and significant distress to patients and families, making prompt recognition and appropriate management essential for improving outcomes 1.